abs113.txt	rna-based		multi-gene	molecular	assays	are	available	and	widely	used	for	patientswith	er-positive/her2-negative	breast	cancers	however	genomic	testscan	be	costly	not	in	many	countries	methods	inferringmolecular	subtype	from	histologic	images	may	identify	patients	most	likely	tobenefit	further	testing	to	who	could	benefit	frommolecular	based	on	h&e	stained	we	developed	an	imageanalysis	approach	using	deep	learning	a	training	set	of	571	tumors	wasused	create	image-based	classifiers	tumor	grade	er	status	pam50intrinsic	risk	recurrence	score	(ror-pt)	theresulting	were	applied	independent	test	(n	=	288)	andaccuracy	sensitivity	specificity	each	was	assessed	the	image	analysis	with	distinguished	low-intermediate	vs	high	(82%	accuracy)	(84%	basal-like	non-basal-like	(77%	ductal	lobular	(94%	low-medium	ror-pt	(75%	sampling	considerations	trainingset	minimized	bias	incorrect	classification	wassignificantly	more	common	luminal	b	these	data	provide	proof	ofprinciple	that	marker	including	critical	clinical	biomarker(i	e	status)	can	predicted	accuracy	>75%	features	promising	identifying	greaterneed	or	place	classically	scored	variablestypically	accomplished	human-based	scoring
